Hospital
Episcopal Health Services INC
Episcopal Health Services INC was paid $46.36M by Medicaid between Jan 2018 and Dec 2024, across 286 billing codes. Its largest line is 99283, emergency room visit (moderate) — 15% of everything it billed.
33Billing provider infoEPISCOPAL HEALTH SERVICES INC
FAR ROCKAWAY, NY 11691
FAR ROCKAWAY, NY 11691
33aNPI1346274537assigned 07/11/2006
33bProvider typePsychiatric Hospital Unit
28Total paid$46.36M
24GClaims742,904
24DCodes billed286
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychiatric Hospital Unit providers in New York
Rank by total paid#6 of 33
Median peer was paid$171K
This provider vs. median271×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,731 | $384K | |
| 2019 | 51,549 | $2.25M | |
| 2020 | 120,031 | $4.97M | |
| 2021 | 163,366 | $6.86M | |
| 2022 | 145,445 | $13.38M | |
| 2023 | 150,381 | $11.77M | |
| 2024incomplete | 103,401 | $6.74M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 30,650 | 27,993 | $6.96M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 41,056 | 34,879 | $6.61M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 12% | 30,984 | 17,076 | $5.52M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.6% | 16,906 | 15,703 | $3.53M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.7% | 12,991 | 12,326 | $3.10M |
| 36415 | Collection of venous blood by venipuncture | 6.1% | 114,114 | 30,647 | $2.85M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.4% | 9,530 | 8,554 | $1.58M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.9% | 6,979 | 6,489 | $1.33M |
| G0378 | Hospital observation service, per hour | 2.3% | 1,468 | 946 | $1.07M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.6% | 1,067 | 468 | $757K |
| 80053 | Comprehensive metabolic panel | 1.6% | 47,935 | 27,252 | $751K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.6% | 5,684 | 5,272 | $724K |
274 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.5% | 6,145 | $717K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.5% | 4,283 | $673K |
| 90834 | Psychotherapy session, about 45 minutes | 1.3% | 2,624 | $581K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.1% | 3,933 | $522K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.0% | 3,914 | $470K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,466 | $444K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,572 | $426K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,778 | $369K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,837 | $337K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 3,294 | $301K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,318 | $301K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 3,083 | $300K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 7,934 | $277K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 2,108 | $271K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 8,716 | $271K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,243 | $267K |
| 59025 | Fetal non-stress test | <1% | 1,900 | $233K |
| 86850 | <1% | 4,594 | $231K | |
| 81025 | <1% | 10,774 | $190K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,238 | $173K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,259 | $149K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,700 | $147K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 954 | $141K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,572 | $134K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 572 | $128K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 767 | $123K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 399 | $121K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 778 | $108K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 6,005 | $107K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 6,301 | $103K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 789 | $97K |
| 76801 | <1% | 1,447 | $89K | |
| 99188 | <1% | 2,273 | $85K | |
| 99443 | <1% | 1,048 | $85K | |
| 86703 | <1% | 4,233 | $80K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,151 | $79K |
| 76641 | <1% | 1,999 | $77K | |
| 86480 | <1% | 1,341 | $76K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,938 | $75K |
| 90686 | <1% | 4,638 | $75K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 453 | $75K |
| 97014 | <1% | 1,898 | $75K | |
| 92551 | <1% | 1,922 | $72K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 3,019 | $65K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 482 | $61K |
| 80061 | Lipid panel | <1% | 5,944 | $60K |
| 76830 | Ultrasound, transvaginal | <1% | 970 | $57K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,057 | $49K |
| 77066 | Tomosynthesis, mammo | <1% | 489 | $47K |
| 99381 | <1% | 375 | $44K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,419 | $44K |
| 98968 | <1% | 1,274 | $43K | |
| 97124 | <1% | 1,559 | $40K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,664 | $39K |
| 90671 | <1% | 801 | $39K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 107 | $39K |
| 83655 | <1% | 2,274 | $38K | |
| 36416 | <1% | 637 | $36K | |
| 96127 | <1% | 3,632 | $35K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 29,049 | $35K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 285 | $34K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 796 | $34K |
| 90715 | <1% | 1,582 | $32K | |
| 90461 | <1% | 2,089 | $31K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,174 | $30K |
| 99442 | <1% | 399 | $29K | |
| 82962 | <1% | 8,581 | $29K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,492 | $28K |
| 99385 | <1% | 148 | $26K | |
| 98967 | <1% | 323 | $24K | |
| 0002A | <1% | 540 | $24K | |
| 83880 | <1% | 1,749 | $23K | |
| 99173 | <1% | 1,735 | $23K | |
| 73630 | <1% | 1,715 | $21K | |
| 97035 | <1% | 1,626 | $20K | |
| 84439 | <1% | 4,872 | $19K | |
| 99383 | <1% | 159 | $19K | |
| 0001A | <1% | 552 | $19K | |
| 90670 | <1% | 1,870 | $18K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 657 | $17K |
| 73562 | <1% | 1,527 | $16K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 836 | $16K |
| 12001 | <1% | 54 | $16K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 123 | $14K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,987 | $14K |
| 90680 | <1% | 1,844 | $14K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,576 | $14K |
| 29581 | <1% | 137 | $13K | |
| 70486 | <1% | 258 | $13K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 255 | $13K |
| 71045 | Radiologic examination, chest; single view | <1% | 6,476 | $13K |
| 86803 | <1% | 1,790 | $13K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,603 | $13K |
| 99441 | <1% | 232 | $13K | |
| 81003 | <1% | 16,556 | $13K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,018 | $12K |
| 90633 | <1% | 1,410 | $12K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,656 | $12K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 436 | $11K |
| 82607 | <1% | 1,393 | $11K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,023 | $10K |
| 73610 | <1% | 961 | $10K | |
| 97802 | <1% | 105 | $10K | |
| 90723 | <1% | 1,261 | $10K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,059 | $9K |
| 10060 | <1% | 41 | $9K | |
| 86762 | <1% | 845 | $9K | |
| 90716 | <1% | 980 | $9K | |
| 90707 | <1% | 1,001 | $9K | |
| 73130 | <1% | 1,077 | $9K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 104 | $9K |
| 0072A | <1% | 105 | $9K | |
| 12011 | <1% | 25 | $9K | |
| 73030 | <1% | 739 | $8K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 157 | $8K |
| 87210 | <1% | 8,986 | $8K | |
| 90647 | <1% | 1,091 | $7K | |
| 93970 | <1% | 38 | $7K | |
| 90648 | <1% | 577 | $7K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 24 | $7K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 188 | $7K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 143 | $6K |
| 99386 | <1% | 29 | $6K | |
| 90662 | <1% | 377 | $6K | |
| 86592 | <1% | 3,438 | $6K | |
| 84702 | <1% | 3,135 | $6K | |
| 94060 | <1% | 44 | $6K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 91 | $6K |
| 82746 | <1% | 808 | $5K | |
| 90688 | <1% | 727 | $5K | |
| 87340 | <1% | 2,143 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,994 | $5K |
| 85730 | <1% | 5,661 | $5K | |
| 85610 | <1% | 6,165 | $5K | |
| 86706 | <1% | 728 | $5K | |
| 91307 | <1% | 48 | $5K | |
| 92550 | <1% | 35 | $4K | |
| 82728 | <1% | 787 | $4K | |
| 93971 | <1% | 59 | $4K | |
| 0071A | <1% | 62 | $4K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 13 | $4K |
| 99384 | <1% | 38 | $4K | |
| 77065 | Tomosynthesis, mammo | <1% | 25 | $4K |
| 90651 | <1% | 410 | $4K | |
| 99382 | <1% | 29 | $4K | |
| 90697 | <1% | 541 | $4K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 22 | $3K |
| J0401 | Injection, aripiprazole (abilify maintena), 1 mg | <1% | 120 | $3K |
| 90656 | <1% | 75 | $3K | |
| 86765 | <1% | 296 | $3K | |
| 90714 | <1% | 211 | $3K | |
| 86787 | <1% | 461 | $3K | |
| 95819 | <1% | 12 | $3K | |
| 97162 | <1% | 31 | $3K | |
| 99051 | <1% | 85 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 94 | $2K |
| 90672 | <1% | 374 | $2K | |
| 90700 | <1% | 268 | $2K | |
| 99401 | <1% | 52 | $2K | |
| 90734 | <1% | 297 | $2K | |
| 76770 | <1% | 12 | $2K | |
| 85027 | <1% | 1,834 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 24 | $2K |
| 91300 | <1% | 783 | $2K | |
| 84484 | <1% | 7,588 | $2K | |
| 97597 | <1% | 15 | $2K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 753 | $2K |
| 87420 | <1% | 892 | $2K | |
| 84703 | <1% | 3,544 | $2K | |
| 83540 | <1% | 617 | $2K | |
| 86710 | <1% | 1,607 | $2K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 426 | $2K |
| 73110 | <1% | 197 | $2K | |
| 0004A | <1% | 26 | $2K | |
| 82043 | <1% | 313 | $1K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,175 | $1K |
| 83020 | <1% | 138 | $1K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 40 | $1K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 57 | $1K |
| 90696 | <1% | 199 | $1K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 26 | $1K |
| 92557 | <1% | 12 | $1K | |
| 84146 | <1% | 69 | $1K | |
| 90620 | <1% | 139 | $1K | |
| 86735 | <1% | 166 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,205 | $971.52 |
| 90746 | <1% | 37 | $969.65 | |
| 83735 | <1% | 2,070 | $959.76 | |
| 29125 | <1% | 12 | $926.65 | |
| 96367 | <1% | 50 | $916.88 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 458 | $908.55 |
| 80320 | <1% | 1,263 | $889.38 | |
| 71250 | <1% | 12 | $886.40 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 680 | $882.87 |
| 83690 | <1% | 4,540 | $866.45 | |
| 72100 | <1% | 71 | $866.23 | |
| 72110 | <1% | 33 | $799.34 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 84 | $779.44 |
| 82550 | <1% | 5,816 | $756.20 | |
| 97161 | <1% | 12 | $756.14 | |
| 11721 | <1% | 16 | $728.91 | |
| 80076 | <1% | 107 | $713.95 | |
| 86900 | <1% | 24 | $679.20 | |
| 90710 | <1% | 88 | $583.45 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 523 | $566.17 |
| 73590 | <1% | 41 | $552.00 | |
| 90685 | <1% | 76 | $535.52 | |
| 84207 | <1% | 13 | $509.80 | |
| 86140 | <1% | 521 | $503.64 | |
| 90480 | <1% | 12 | $493.04 | |
| 81401 | <1% | 16 | $479.09 | |
| 86704 | <1% | 84 | $464.28 | |
| 97164 | <1% | 67 | $458.96 | |
| 83605 | <1% | 2,840 | $403.11 | |
| 82465 | <1% | 249 | $386.23 | |
| 73080 | <1% | 42 | $366.15 | |
| 73090 | <1% | 27 | $321.72 | |
| 0003A | <1% | 12 | $318.00 | |
| 85651 | <1% | 464 | $312.48 | |
| 86256 | <1% | 14 | $308.20 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 13 | $307.42 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 584 | $299.35 |
| 87102 | <1% | 31 | $297.55 | |
| J3490 | Unclassified drugs | <1% | 655 | $292.57 |
| 82553 | <1% | 2,228 | $274.22 | |
| 83550 | <1% | 124 | $254.21 | |
| 82947 | <1% | 54 | $231.62 | |
| 84100 | <1% | 516 | $222.46 | |
| 97803 | <1% | 13 | $191.73 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,239 | $190.33 |
| 85048 | <1% | 223 | $188.62 | |
| 96380 | <1% | 13 | $182.23 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,876 | $169.93 |
| 90750 | <1% | 13 | $167.69 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,533 | $161.30 |
| 85378 | <1% | 1,113 | $157.58 | |
| 82803 | <1% | 140 | $145.65 | |
| 85007 | <1% | 2,292 | $145.09 | |
| 87070 | <1% | 68 | $130.40 | |
| 84132 | <1% | 1,220 | $124.11 | |
| 87040 | <1% | 750 | $92.43 | |
| 96376 | <1% | 537 | $91.36 | |
| 86708 | <1% | 24 | $70.70 | |
| 94760 | <1% | 2,259 | $67.32 | |
| 82570 | <1% | 28 | $65.44 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | <1% | 221 | $57.75 |
| 83615 | <1% | 190 | $56.35 | |
| 82009 | <1% | 298 | $53.50 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 880 | $52.07 |
| 80164 | <1% | 17 | $49.50 | |
| 84155 | <1% | 24 | $37.33 | |
| 87184 | <1% | 20 | $32.95 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,020 | $32.70 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 1,048 | $29.05 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,432 | $23.22 |
| 74018 | <1% | 15 | $20.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 27 | $16.60 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 773 | $11.94 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 923 | $5.09 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 621 | $4.71 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 206 | $3.08 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 273 | $2.25 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 268 | $0.42 |
| 90381 | <1% | 12 | $0.07 | |
| 90380 | <1% | 13 | $0.07 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 28 | $0.00 |
| 94761 | 0% | 28 | $0.00 | |
| 74019 | 0% | 14 | $0.00 | |
| J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg | 0% | 12 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 13 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 114 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 13 | $0.00 |
| 99080 | 0% | 464 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGUIDO, STEVEN (CFO - CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Episcopal Health Services INC | Far Rockaway, NY | $4.19M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.